CD19 Chimeric Antigen Receptors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19 Chimeric Antigen Receptors, covering 2023-02-10 to 2023-02-10. Get the full timeline:
Most recent: Clinical Trial Update: CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment [Phase 1, Phase 2]